콘드로이틴 황산 시장 보고서 : 공급원별, 형태별, 용도별, 지역별(2025-2033년)

The global chondroitin sulfate market size reached USD 1.58 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 2.10 Billion by 2033, exhibiting a growth rate (CAGR) of 3.07% during 2025-2033. The market is primarily driven by increasing demand in nutraceuticals and pharmaceuticals for joint care. Moreover, technological advancements and an elevated awareness of preventive healthcare significantly contribute to market growth. Additionally, magnifying aging population and strategic collaborations further spur innovation as well as market expansion.

Chondroitin Sulfate Market Trends:

Rising Product Demand in the Pharmaceutical Sector

Chondroitin sulfate is gaining momentum in the pharmaceutical sector primarily for its therapeutic benefits that include its potential in treating osteoarthritis and various other joint disorders. According to WHO, 70% people suffering with osteoarthritis are older than 55, while 60% people suffering with this degenerative disorder are women. Moreover, 344 million individuals are experiencing severe levels of osteoarthritis. Resultantly, pharmaceutical companies are currently investing in research and development (R&D) to produce advanced formulations that can improve the efficacy and bioavailability of chondroitin sulfate. This trend is further driven by the escalating demand for safe and effective treatment options for joint health. Moreover, regulatory clearances and heightening clinical evidence supporting the efficiency of chondroitin sulfate are fostering its adoption in the pharmaceutical industry.

Advancements in Production and Extraction Technologies

The ongoing research and advancements in production and extraction techniques is significantly profiting the chondroitin sulfate market growth by enhancing the quality and efficiency of the product. Innovation such as enzyme-based extraction techniques and biotechnological processes are lowering production costs and improving the grade of the final product. Such technological advancements are allowing manufacturers to address the rising demand more cost-efficiently and sustainably. In addition, such advancements include investigating chondroitin sulfate's potential advantages in mitigating other medical conditions and enhancing its bioavailability through advanced formulation technologies. For instance, according to a research study published in May 2024, nanocapsules were developed with amphiphilic chondroitin sulfate-based shells and liquid oil cores, which exhibited excellent biocompatibility with human skin cells and were proven to be highly stable carriers for the topical delivery of lipophilic bioactive compounds

Expanding Applications in Nutraceuticals and Dietary Supplements

The chondroitin sulfate market report accentuates that the nutraceuticals and dietary supplements sector is majorly steering the market growth by heavily leveraging the product. Consumers are intensely seeking supplements for joint health due to rising awareness of aging-related osteoarthritis and other joint issues. Consequently, chondroitin sulfate is rapidly being utilized as a key ingredient in numerous supplements and nutraceuticals due to its ability of alleviating joint pain and maintaining cartilage health. This trend is further bolstered by the rapid elevation in aging global population and increasing incidents of sport-related injuries, which fuel the requirement for effective joint health treatments. According to WHO, 1 in 6 people globally will be aged 60 years or over by 2030. Moreover, the number of individuals aged 80 years or older is projected to reach 426 million by 2050.

Chondroitin Sulfate Market Segmentation:

Breakup by Source:

• Bovine
• Swine
• Poultry
• Shark
• Others

Bovine accounts for the majority of the market share

The chondroitin sulfate market outlook points to substantial domination of bovine segment as the extraction source of the product, pertaining to its excellent efficacy and abundant availability. The preference for bovine sources is boosted by the cost-effectiveness, consistent quality, and established extraction technologies. According to industry reports, 500,000 liters of fetal bovine serum is produced annually. Additionally, this requires harvest of approximately 1 million bovine fetuses. Moreover, the widespread use of bovine-derived chondroitin sulfate in nutraceutical and pharmaceutical applications highlights its dominance in the global market dynamics. This trend is further fueled by the rising consumer awareness of degenerative diseases related to joints and the rapid escalation of the aging population around the world.

Breakup by Form:

• Powder
• Tablet
• Others

Powder holds the largest share of the industry

Powder forms holds the largest market share principally due to its versatile profile and ease of incorporation into numerous products, including cosmetics, dietary supplements, and pharmaceuticals. According to the chondroitin sulfate market overview, powder form is a preferred choice for manufacturers due to its cost-effectiveness, excellent stability, and longer shelf life. Furthermore, the powdered form ensures accurate dosing and efficient absorption, catering to the rising demand for therapeutic applications and joint health supplements. According to the Council for Responsible Nutrition, 74% of the adults in U.S. took dietary supplements in 2023, while 55% consumers were found to be regular users of these supplements. Consequently, this propels the demand for powdered chondroitin sulfate in the supplementary sector, ultimately strengthening the segment dominance in the global market.

Breakup by Application:

• Pharmaceuticals and Nutraceuticals
• Animal Feed
• Personal Care and Cosmetics
• Others

Pharmaceuticals and Nutraceuticals represents the leading market segment

According to the chondroitin sulfate market forecast, the pharmaceutical and nutraceutical segment is prospected to sustain its dominance in the global market chiefly due to the magnifying demand for nutraceutical solutions for osteoarthritis and supplements for joint health. The global elevation in the aging population and intensifying awareness of preventive healthcare are key factors that fuel this trend. Moreover, chondroitin sulfate's proven efficiency in mitigating joint pian and enhancing cartilage health positions it as a preferable ingredient in numerous pharmaceutical formulations and supplements. Consequently, major pharmaceutical companies are currently focusing on incorporating chondroitin sulfate in joint care supplements for both humans and animals. For instance, in May 2023, Virbac, a company dedicated to animal health, launched a joint care supplement for dogs named Movoflex which contains active ingredient Biovaflex eggshell membrane as a major source of chondroitin sulfate.

Breakup by Region:

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa

North America leads the market, accounting for the largest chondroitin sulfate market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for chondroitin sulfate.

North America accounts for the largest regional market share due to its well-established healthcare infrastructure and increasing prevalence of osteoarthritis. According to Osteoarthritis Action Alliance, 53.2 million people in United States are reported to affected with some form of arthritis. Furthermore, 32.5 million U.S. adults are suffering with osteoarthritis. In addition, chondroitin sulfate market recent developments such as amplified investments in research for advanced joint care supplements and the introduction of new standards-compliant nutraceutical products further sustains North America's leadership in the global market. Moreover, the region's increasing demand for effective pharmaceutical solutions for joint pain and elevating number of aged individuals significantly boost market growth.

Competitive Landscape:

• The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the chondroitin sulfate industry include Bioiberica S.A.U., BRF S.A., HeBei SanXin Industrial Group, Maypro Industries Inc., Merck KGaA, Pacific Rainbow International Inc., Qingdao Wantuming Biological Products Co. Ltd., Seikagaku Corporation, Sino Siam Biotechnique Company Limited, Sioux Pharm Inc., Synutra International Inc. and ZPD A/S.

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

• The global market is extremely competitive, represented by numerous chondroitin sulfate companies striving for dominance in market share through strategic partnerships and innovations. Key players are currently focusing on improving product quality and diversifying their product portfolio to cater to the diverse consumer demands. Extensive R&D investments and regulatory approvals are also crucial for maintaining a competitive lead. Additionally, tactical collaborations and awareness campaigns for joint care and joint-related degenerative diseases facilitates the companies to solidify their global presence and endorse their product line. For instance, in July 2024, Borsch Med collaborated with Zeria's Chondro Max to launch Ikigai Health Campaign in Singapore where importance of chondroitin sulfate levels in the body was highlighted and newly launched chondroitin-based products by Zeria were promoted.

Key Questions Answered in This Report:

• How has the global chondroitin sulfate market performed so far, and how will it perform in the coming years?
• What are the drivers, restraints, and opportunities in the global chondroitin sulfate market?
• What is the impact of each driver, restraint, and opportunity on the global chondroitin sulfate market?
• What are the key regional markets?
• Which countries represent the most attractive chondroitin sulfate market?
• What is the breakup of the market based on the source?
• Which is the most attractive source in the chondroitin sulfate market?
• What is the breakup of the market based on the form?
• Which is the most attractive form in the chondroitin sulfate market?
• What is the breakup of the market based on the application?
• Which is the most attractive application in the chondroitin sulfate market?
• What is the competitive structure of the market?
• Who are the key players/companies in the global chondroitin sulfate market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Chondroitin Sulfate Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Source

• 6.1 Bovine
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Swine
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Poultry
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast
• 6.4 Shark
  • 6.4.1 Market Trends
  • 6.4.2 Market Forecast
• 6.5 Others
  • 6.5.1 Market Trends
  • 6.5.2 Market Forecast

7 Market Breakup by Form

• 7.1 Powder
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Tablet
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Others
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast

8 Market Breakup by Application

• 8.1 Pharmaceuticals and Nutraceuticals
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Animal Feed
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Personal Care and Cosmetics
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Others
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast

9 Market Breakup by Region

• 9.1 North America
  • 9.1.1 United States
    • 9.1.1.1 Market Trends
    • 9.1.1.2 Market Forecast
  • 9.1.2 Canada
    • 9.1.2.1 Market Trends
    • 9.1.2.2 Market Forecast
• 9.2 Asia-Pacific
  • 9.2.1 China
    • 9.2.1.1 Market Trends
    • 9.2.1.2 Market Forecast
  • 9.2.2 Japan
    • 9.2.2.1 Market Trends
    • 9.2.2.2 Market Forecast
  • 9.2.3 India
    • 9.2.3.1 Market Trends
    • 9.2.3.2 Market Forecast
  • 9.2.4 South Korea
    • 9.2.4.1 Market Trends
    • 9.2.4.2 Market Forecast
  • 9.2.5 Australia
    • 9.2.5.1 Market Trends
    • 9.2.5.2 Market Forecast
  • 9.2.6 Indonesia
    • 9.2.6.1 Market Trends
    • 9.2.6.2 Market Forecast
  • 9.2.7 Others
    • 9.2.7.1 Market Trends
    • 9.2.7.2 Market Forecast
• 9.3 Europe
  • 9.3.1 Germany
    • 9.3.1.1 Market Trends
    • 9.3.1.2 Market Forecast
  • 9.3.2 France
    • 9.3.2.1 Market Trends
    • 9.3.2.2 Market Forecast
  • 9.3.3 United Kingdom
    • 9.3.3.1 Market Trends
    • 9.3.3.2 Market Forecast
  • 9.3.4 Italy
    • 9.3.4.1 Market Trends
    • 9.3.4.2 Market Forecast
  • 9.3.5 Spain
    • 9.3.5.1 Market Trends
    • 9.3.5.2 Market Forecast
  • 9.3.6 Russia
    • 9.3.6.1 Market Trends
    • 9.3.6.2 Market Forecast
  • 9.3.7 Others
    • 9.3.7.1 Market Trends
    • 9.3.7.2 Market Forecast
• 9.4 Latin America
  • 9.4.1 Brazil
    • 9.4.1.1 Market Trends
    • 9.4.1.2 Market Forecast
  • 9.4.2 Mexico
    • 9.4.2.1 Market Trends
    • 9.4.2.2 Market Forecast
  • 9.4.3 Others
    • 9.4.3.1 Market Trends
    • 9.4.3.2 Market Forecast
• 9.5 Middle East and Africa
  • 9.5.1 Market Trends
  • 9.5.2 Market Breakup by Country
  • 9.5.3 Market Forecast

10 SWOT Analysis

• 10.1 Overview
• 10.2 Strengths
• 10.3 Weaknesses
• 10.4 Opportunities
• 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

• 12.1 Overview
• 12.2 Bargaining Power of Buyers
• 12.3 Bargaining Power of Suppliers
• 12.4 Degree of Competition
• 12.5 Threat of New Entrants
• 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

• 14.1 Market Structure
• 14.2 Key Players
• 14.3 Profiles of Key Players
  • 14.3.1 Bioiberica S.A.U.
    • 14.3.1.1 Company Overview
    • 14.3.1.2 Product Portfolio
  • 14.3.2 BRF S.A.
    • 14.3.2.1 Company Overview
    • 14.3.2.2 Product Portfolio
    • 14.3.2.3 Financials
    • 14.3.2.4 SWOT Analysis
  • 14.3.3 HeBei SanXin Industrial Group
    • 14.3.3.1 Company Overview
    • 14.3.3.2 Product Portfolio
  • 14.3.4 Maypro Industries Inc.
    • 14.3.4.1 Company Overview
    • 14.3.4.2 Product Portfolio
  • 14.3.5 Merck KGaA
    • 14.3.5.1 Company Overview
    • 14.3.5.2 Product Portfolio
    • 14.3.5.3 Financials
    • 14.3.5.4 SWOT Analysis
  • 14.3.6 Pacific Rainbow International Inc.
    • 14.3.6.1 Company Overview
    • 14.3.6.2 Product Portfolio
  • 14.3.7 Qingdao Wantuming Biological Products Co. Ltd.
    • 14.3.7.1 Company Overview
    • 14.3.7.2 Product Portfolio
  • 14.3.8 Seikagaku Corporation
    • 14.3.8.1 Company Overview
    • 14.3.8.2 Product Portfolio
    • 14.3.8.3 Financials
  • 14.3.9 Sino Siam Biotechnique Company Limited
    • 14.3.9.1 Company Overview
    • 14.3.9.2 Product Portfolio
  • 14.3.10 Sioux Pharm Inc.
    • 14.3.10.1 Company Overview
    • 14.3.10.2 Product Portfolio
  • 14.3.11 Synutra International Inc.
    • 14.3.11.1 Company Overview
    • 14.3.11.2 Product Portfolio
  • 14.3.12 ZPD A/S
    • 14.3.12.1 Company Overview
    • 14.3.12.2 Product Portfolio